Efficacy of ex vivo activated and expanded natural killer cells and T lymphocytes for colorectal cancer patients.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Biomedical Reports

• Publication date

  2014-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/BR.2014.264PMID 24944796PMCID PMC4051481
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multi-modality treatment of colorectal liver metastases.

  2012cited by this paper
• Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.

  2011cited by this paper
• Massive ex Vivo Expansion of Human Natural Regulatory T Cells (Tregs) with Minimal Loss of in Vivo Functional Activity

  2011cited by this paper
• Expansion, purification, and functional assessment of human peripheral blood NK cells.

  2011cited by this paper
• Cytokine Induced Killer Cells as Promising Immunotherapy for Solid Tumors

  2011cited by this paper
• Immunotherapy targeting colon cancer stem cells.

  2011cited by this paper
• In Vitro Stimulation and Expansion of Human Tumour‐Reactive CD8+ Cytotoxic T Lymphocytes by Anti‐CD3/CD28/CD137 Magnetic Beads

  2011cited by this paper
• Ex vivo Expansion of CD56+ NK and NKT‐like Lymphocytes from Peripheral Blood Mononuclear Cells of Patients with Ovarian Neoplasia

  2011cited by this paper
• Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach

  2011cited by this paper
• Management of stage IV rectal cancer: palliative options.

  2011cited by this paper
• NK cell-based immunotherapy for treating cancer: will it be promising?

  2011cited by this paper
• Clinical outcomes of active specific immunotherapy in advanced colorectal cancer and suspected minimal residual colorectal cancer: a meta-analysis and system review

  2011cited by this paper
• Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience.

  2010cited by this paper
• Significance of serum concentrations of E-selectin and CA19-9 in the prognosis of colorectal cancer.

  2010cited by this paper
• Colorectal cancer

  2010cited by this paper
• Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.

  2009cited by this paper
• Adverse Events Following Infusion of T Cells for Adoptive Immunotherapy: A 10 Year Experience.

  2009cited by this paper
• Large-Scale Production and Characterization of Novel CD4+ Cytotoxic T Cells with Broad Tumor Specificity for Immunotherapy

  2009cited by this paper
• Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1.

  2008cited by this paper
• Adoptive cell transfer: a clinical path to effective cancer immunotherapy

  2008cited by this paper
• Natural killer cell–directed therapies: moving from unexpected results to successful strategies

  2008cited by this paper
• Adoptive cellular immunotherapy for childhood malignancies

  2008cited by this paper
• Natural killer cell immunotherapy for cancer: a new hope.

  2008cited by this paper
• Potential Role of NK Cells in the Induction of Immune Responses: Implications for NK Cell–Based Immunotherapy for Cancers and Viral Infections

  2008cited by this paper
• Emerging therapies for melanoma

  2008cited by this paper
• Immunotherapy opportunities in ovarian cancer

  2008cited by this paper
• Palliation of colorectal cancer.

  2007cited by this paper
• Carbohydrate antigen sialyl Lewis a--its pathophysiological significance and induction mechanism in cancer progression.

  2007cited by this paper
• Recent developments in renal cell cancer immunotherapy

  2007cited by this paper
• Cellular immunotherapies for prostate cancer.

  2007cited by this paper
• Potential role of natural killer cells in controlling growth and infiltration of AIDS‐associated primary effusion lymphoma cells

  2006cited by this paper
• Dendritic Cell Vaccination in Medullary Thyroid Carcinoma

  2004cited by this paper
• Palliative care for colorectal cancer.

  2004cited by this paper
• Breast cancer immunotherapy.

  2004cited by this paper
• Colorectal cancer

  1993cited by this paper
• Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells.

  1991cited by this paper

• Exploration of the role of immune cells and cell therapy in hepatocellular carcinoma

  2025cites this paper
• Evaluating the Safety and Quality of Life of Colorectal Cancer Patients Treated by Autologous Immune Enhancement Therapy (AIET) in Vinmec International Hospitals

  2022cites this paper
• Enhancement of NK Cell Cytotoxicity against MDA-MB-231 Cell by Presence of OK432

  2019cites this paper
• Enhancement of NK Cell-Mediated Lysis of Osteosarcoma Cells by Up-Regulating the NKG2D Ligands using Spironolactone and AVE

  2019cites this paper
• Effect of Aging on NK Cell Population and Their Proliferation at Ex Vivo Culture Condition

  2018cites this paper
• Epirubicin pretreatment enhances NK cell-mediated cytotoxicity against breast cancer cells in vitro.

  2016cites this paper
• Stem and immune cells in colorectal primary tumour: Number and function of subsets may diagnose metastasis

  2015cites this paper